chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; Pain at site of injection; Chills; This is a spontaneous report from a non-contactable healthcare professional (HCP) (Patient). A 43-year-old non-pregnant female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on 15Jan2021 19:45 at a single dose in left arm for COVID-19 immunization. There were no medical history or concomitant medications. No known allergies. No other vaccine in four weeks and no other medications in two weeks. On 16Jan2021, the patient experienced headache, pain at site of injection, chills. No treatment received for events. The adverse event did not result in 'doctor or other HCP visit or emergency room or urgent care, hospitalization or prolongation, life threatening illness, disability or death or congential anomaly'. No COVID prior vaccination and no COVID tested post vaccination. The outcome of events was recovered on an unspecified date in Jan2021.   No follow-up attempts are possible. Information about batch/ lot number cannot be obtained. No further information expected.
Fever - 107F Abdominal Pain Vomiting Bloody Nose Sore Throat 11/09/09 HMO PCP and ED medical records received service dates 11/1/09 to 11/2/09. Assessment: Influenza like illness. Presents at ED. Parent reports child has fever, headache, dizziness. Also complained of abdominal pain and vomited. Sore throat. Next day parent states child running around happily.
I experienced body aches all over and pain at injection site. These symptoms lasted through March 11th, 2021. Woke up  March 12th with no symptoms other than slight tiredness.
HEADACHE; CONGESTION; RUNNY NOSE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 16-MAR-2021, the subject experienced runny nose. On 17-MAR-2021, the subject experienced congestion. On 22-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, runny nose, and congestion. This report was non-serious.
migraine increased; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine increased) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine (Prone to migraines).  On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (migraine increased). At the time of the report, MIGRAINE (migraine increased) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  Treatment information was not provided.
when she received her second dose, it bled; fingers numb on her left side, little finger and ring finger on her left hand are still numb; fingertips to elbow cold inside; fingers tingly on her left side where she received vaccine, little finger and ring finger on her left hand are still tingly up to her elbow; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE HAEMORRHAGE (when she received her second dose, it bled), HYPOAESTHESIA (fingers numb on her left side, little finger and ring finger on her left hand are still numb), FEELING COLD (fingertips to elbow cold inside) and PARAESTHESIA (fingers tingly on her left side where she received vaccine, little finger and ring finger on her left hand are still tingly up to her elbow) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 022M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021 at 9:45 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced HYPOAESTHESIA (fingers numb on her left side, little finger and ring finger on her left hand are still numb), FEELING COLD (fingertips to elbow cold inside) and PARAESTHESIA (fingers tingly on her left side where she received vaccine, little finger and ring finger on her left hand are still tingly up to her elbow). On 01-Apr-2021 at 9:45 AM, the patient experienced VACCINATION SITE HAEMORRHAGE (when she received her second dose, it bled). At the time of the report, VACCINATION SITE HAEMORRHAGE (when she received her second dose, it bled) outcome was unknown and HYPOAESTHESIA (fingers numb on her left side, little finger and ring finger on her left hand are still numb), FEELING COLD (fingertips to elbow cold inside) and PARAESTHESIA (fingers tingly on her left side where she received vaccine, little finger and ring finger on her left hand are still tingly up to her elbow) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information were not reported. Action taken with mRNA-1273 in response to the events was not Applicable.  Company comment:Based on the current information and the temporal association between the events and the use of the product a causal relationship cannot be excluded.   This case was linked to MOD-2021-065431 (Patient Link).; Sender's Comments: Based on the current information and the temporal association between the events and the use of the product a causal relationship cannot be excluded.
Patient received second dose of his Pfizer vaccine on 3/25/21  and developed acute chest pain found to have myopericarditis.
Received the shot at 8:05 am and initially did not feel anything.  I went back to work and at around 10:00 am, I realized I was coughing due to a film in the back of my throat, it was itching, my tongue is slightly swollen and itchy.  I have a migraine and I feel dizzy.
Client was getting ready to leave after 15 minutes observation and he attempted to get up, felt dizzy, fell backwards and fell to ground.  He appeared dazed for less than 30 seconds.  No difficulty breathing, no shortness of breath.  Able to answer questions appropriately,  alert, oriented x 3, stated he felt okay.  911 called.  B/P 139/82 right arm, HR72,  RR18.  Pt continued to feel fine, answering questions. appropriately.  No history of vaccine reaction.  Medication for stomach taken.  Per client no heart, or diabetes history.   Client stated he last ate breakfast and had a little bit of coffee.   He refused medical treatment and his son drove him home.
At 2am 4/22 patient started to feel sick and sent a text that I didn't read until 630 as I was asleep.  She had severe muscle aches, hurt to move, hurt to breathe and felt like she was having a heart attack.  She felt like she might pass out and had some blurred vision.  At 630am, I  saw her texts and immediately brought her 2 tylenol and a large glass of water.  She went back to bed.  She woke up around 10:45 and was feeling decent except for a headache but no fever or anything so we went to try on some Prom dresses.  At the dress shop, she collapsed and had a seizure lasting around a minute.  She lost her bladder and was completely confused and incoherent.  She's never had a seizure before.  I scooped her up, brought her to the ER where they ran every test and scan imagineable.  Full blood work up and cultures, a chest xray, a CT scan of her brain and lungs.  Her temp was high 103-104 and she had full body chills and a pounding headache.  Her BP kept dropping and got as low as 81/36.  They threw 2 bags of IV fluids into her and admitted her to the hospital.  She had also developed a heart murmur.  Over the course of the night, her BP stabilized but her temp continued to spike and come back down with Tylenol/Ibuprofen.  She also had IV Tordahl for the headache.  Her inflammatory markers were high at 15.3 which we were told should be less than 1.  They reran labs in the morning but everything can back really low which they felt was a dilution effect from all the fluids so wanted us to follow up with her primary care on Monday.  On Saturday night, he lymph nodes were swollen to the size of ping pong balls but have since slowly reduced in size although still there.  Her labs were better from discharge and her white blood cell count was within range and her inflammatory marker was down to 1.7.   Her blood sugar was a little low.  She did pass out and have seizure like response to giving blood in the doctors office,  lost bladder control again, shot pupils, etc.  She is still stuttering over words, has some short term memory retention and has some motor function issues which they think is a result of the initial seizure and should resolve itself over time.  Her liver function tests were totally normal in the hospital but are a high now so they will be checking her out again next week.
Patient developed cellulitis after injection. The site is warm to touch with erythema. Patient stated " I received a meningococcal vaccine but I'm not sure which one"
no adverse event; Monovalent dose administered after the BUD to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event) in a 63-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient).    No concomitant medications were reported. It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment information was not provided.
Patient received vaccine and was seated in a chair waiting for 15 minute observation period, after about 5 to 10 minutes patient fell out of chair and hit head on ground and bit his tongue, 911 was called and he was taken via ambulance to hospital for further evaluation
4 days post dose 1, arm pain at injection site, unable to move arm that continues for 21 days past dose 1.
Nothing until March 7th... throwing up, fever and chills, stomach pains for 2 days. March 12 began itching severely on hands, fingers swelling, no relief. Are symptoms of auto immune disorder, but hasn?t appeared since treatment began in 2013.  Basically kicked my auto immune disorder ?back on? after 7 years of treatment.
Pfizer-BioNTech Covid-19 Vaccine Received vaccine Monday morning- no issues until Wednesday other than slight arm pain at the injection site. Wednesday morning,  woke up with chills, sweating, vomiting, and a headache.  Chills, sweating, tiredness were strong for 8 hours, lessened over the next 12 hours. Headache increased and remained present until Friday afternoon.
Minor muscular discomfort since date of injection ~2 months ago @ site of injection when moving L arm.  No pain when at rest.  Previous Td 1989 or 1990. Follow up information received on 7/19/06 states - No known date of onset of adverse event. Patient reported "muscular disconfort" at site of injection 2 months following receipt of immunization.
The morning after the shot I woke up with a puffy/swollen right eye. Eventually I experienced itching in the area, and today (two days later, both eyes are slightly swollen and I have areas of itching on my face and neck. I?m not experiencing any throat swelling or trouble breathing, but I thought this was a bit unusual and might be something to report. I took Benadryl on the night of the 25th and it helped some. I?m not particularly concerned, but would be interested to know if others have experienced similar symptoms and if it might be worse if I were to receive a booster some day. I did not experience any symptoms with the first dose, apart from a sore arm.
Patient states Wednesday night, 9/16/20, she started having trouble with her eye itching and she started biting on her mouth and lip and it appeared to look crooked. Patient states she also has trouble drinking without spilling it on her, almost as if her mouth feels paralyzed. Patient contacted her primary care doctor on 9/17/20 who instructed her to go to the ER. ER doctor told patient she believed patient may have a case of shingles that has caused Bell's palsy. ER doctor sent in Prednisone 20 mg tablets and valacyclovir 1 gm tablets. However, patient denies having a rash or any other sign or symptom of shingles.
10 days p/vax pt devel rheumatic arthritis in all joints & lost use of her legs lasting 1 mon.Unable to walk for 2 wk.After extensive testing pt was determined to have serum sickness.
Low grade fever 12 hours after injection for about 4 hours. Sever shoulder pain with restricted movement lasted 48 hours. Shoulder still very tender to touch.
I had the old shingles shoT in March of 2011 wiTh no reacTion. over
Initial unsolicited report received from a nurse on 16 Jun 2016. This case is linked to 2016SA114797 (same reporter). This case involves a male patient (one of the two boys, age not reported) who was vaccinated with first dose of YELLOW FEVER VACCINE (lot number: UI291AA, expiration date: 20 Apr 2018, dose, route of administration not reported) in deltoid on 13 Jun 2016. The medical history including any allergies, illness at time of vaccination were reported as none. It was unknown whether the patient received any concomitant medications and if any other vaccine administered to the patient within 4 weeks of the suspect vaccine. On 14 Jun 2016, one day after vaccination, the patient experienced pain in the axilla. The reporter planned to advise the mother to take the patient to see their pediatrician and have them evaluated for their symptoms. It was reported that patient required doctor visit. The lab data was reported as none. Corrective treatment was not reported. The outcome for the events was reported as unknown. List of documents held by sender: none.
Patient was given Tdap and PPD for employee health on 7-16-07. Presented today with c/o systemic bodyaches, nausea, chills, per patient had fever, and fatigue. No erythema at injection site pain at Tdap injection site.
A few months after the Janssen vaccination, I started hurting in my bones.  My wrist, my feet, my ankles, my shoulders.  I had my primary care physician run a blood test for rheumatoid arthritis and it came back as positive.
Suspected vaccination failure; I know 6 people that got the shot and then got shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The age at vaccination was not reported. The reporter reported that, he/she knew the patient who received Shingles vaccine and then got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of singles were not provided.    This was 1 of 6 linked cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR161278:Same reporter. Pt 2/6 US-GLAXOSMITHKLINE-US2021AMR161279:Same reporter. Pt 3/6 US-GLAXOSMITHKLINE-US2021AMR161280:Same reporter. Pt 4/6 US-GLAXOSMITHKLINE-US2021AMR161281:Same reporter. Pt 5/6 US-GLAXOSMITHKLINE-US2021AMR161267:Same reporter. Pt 1/6
Extreme confusion, symptoms similar to stroke, legs weak, could not stand or walk.   Difficulty forming words.  Words were very garbelled.  Extremes sweatness.  chills.
Employee received 1st dose of Modera Covid Vaccine on 1/04/21 and 2nd dose 2/01/21 Employee reports onset of sxs of nasal congestion and HA on 5/11/21. Employee tested for Covid on 5/13/21 resulting in positive test and low CT count.  OCH reporting on employee having a positive covid test w/ sxs post receiving both Moderna covid vaccines.
Sedation, Myalgia, Arthralgia, Fever, chills and fatigue. pain, redness and swelling at the injection site Narrative:
patient received the first dose of Havrix in 2015 and a booster dose in 8-21-23; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too long in a 9-year-old male patient who received HAV (Havrix) (batch number Y3ME2, expiry date 23-FEB-2025) for prophylaxis.   Previously administered products included Havrix (1st dose received in 2015).   On 21-AUG-2023, the patient received the 2nd dose of Havrix. On 21-AUG-2023, an unknown time after receiving Havrix, the patient experienced drug dose administration interval too long (Verbatim: patient received the first dose of Havrix in 2015 and a booster dose in 8-21-23).  The outcome of the drug dose administration interval too long was unknown.   Additional Information: Receipt Date:24-AUG-2023 Medical assistant calls to report a patient received the first dose of Havrix in 2015 and a booster dose in 21st August 2023 which led to lengthening of vaccination schedule. The reporter consented to follow up via email.
Moderate joint pain and  joint swelling.  Vaccination was 7/23, joint pain began 7/28.
Client presented with shortness of breath, anxiety, diaphoresis at 12:00 pm, 15 minutes after receiving first dose of Moderna vaccine at outreach clinic at her apartment residence.   12:03 VS 152/94, 94 bpm regular.  12:05 50 mg of dyphenhydramine IM in her left arm 12:15 Her nebulizer was retrieved from her apartment, during which time client contacted her daughter to come for assistance.  12:20 Reported continued breathing difficulties, but felt the "benadryl was helping" and appeared less anxious. HR 94 (BP deferred while client was calling her daughter)  12:23 she obtained her nebulizer and took an albuterol treatment over 15 minutes, reporting good effect and improvement in symptoms.  12:36  112/68 95 HR sinus rhythm.   She still felt like her heart was racing, w/ 95 bpm.  Reported feeling "light headed" (counseled that benadryl and albuterol could contribute to this symptom), but "better" and "can breathe easier".   12:50 Daughter arrived, was given report on above, advised to check client's blood glucose, administer insulin if indicated, as ordered and follow with something to eat.  Advised to contact client's PCP for further concerns. We will contact client tomorrow to F/U
Received vaccine on 5-6-21.  On 5-8-21, complained of headache, bloating, fever, and constipation.  Last seen alive at 9 PM on 5-8.  Found dead at home at 7 PM on 5-9.
Redness, itching at injection site and down arm to bicep.  Area is warm to touch and red with slight swelling. Concern for early cellulitis Patient rx'ed Keflex but advised only to start if symptoms worsen.  Treat currently with Benadryl and ice.
Erythema, swelling, warmth, around site of injection 24 hours after injection. No fever, no pain.
Patient had a visit on 7/14/2023 at 0930 .  Nurse remembers opening a new vial on this day.  Patient aslo got a monkeypox vaccine during this visit. on 7/14/2023, there were 2 doses extra left over in the same lot number, when there should have been 0 per internal inventory, Since it is not possible to pinpoint which doses caused the overage, it appears 1 or more doses given between 6/9/2023 and 7/7/2023 may have been expired- 12 hours after opening and reused, therefore all doses given during that period are considered to potentially be expired.
Started with slightly sore arm, and a headache, headache got worse, took advil, didn't sleep well, severe headache, muscle and joint pain, took more advil.  Morning, felt like a flu, slight fever, body aches, joints, major pain trying to lift left (shot) arm.  Not severe enough to seek medical attention.
BODY ACHE; INSATIABLE THIRST; FEVER; BAD HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) administered on 28-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported. Per procedure, no follow-up will be requested for this case. On 28-MAR-2021, the subject experienced fever. On 28-MAR-2021, the subject experienced body ache. On 28-MAR-2021, the subject experienced bad headache. On 28-MAR-2021, the subject experienced insatiable thirst. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, body ache, bad headache, and insatiable thirst on 30-MAR-2021. This report was non-serious.
c/o throat feeling tight and later in the early afternoon had some eye and facial swelling. Took Benadryl po.
Within minutes of the patient receiving the vaccine, she passed out.  She was unable to communicate for appropriate 15 minutes and then could only respond with hand motions, eye movement and facial expression.   Parents took her home.  Once home, she didn't speak for almost 24 hours.  She had random arm movement like seizure activity.   Head would shake violent.   Patient was seen by physician  5 days later, with blurred double vision and still not back to normal.   She also went to her eye doctor that same week and was diagnosed with double vision, potentially caused by the vaccine.   The doctor is not certain that it was caused by the vaccine but could be potentially.